Ami Grunbaum

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Coronavirus Disease

Circulating Tumor Cells

Top Venues

ACS pharmacology & translational science

Clinical toxicology (Philadelphia, Pa.)

This page only lists publications with an associated author ORCID identifier.

Publications

Ketki S Bhalerao, P I Thilini De Silva, Keshani Hiniduma, Ami Grunbaum, Nicholas Rozza, Richard Kremer, James F Rusling
Microfluidic Immunoarray for Point-of-Care Detection of Cytokines in COVID-19 Patients. ACS omega 9 (27) (2024)
Ketki S Bhalerao, P I Thilini De Silva, Keshani Hiniduma, Ami Grunbaum, Nicholas Rozza, Richard Kremer, James F Rusling
Microfluidic Immunoarray for Point-of-Care Detection of Cytokines in COVID-19 Patients. ACS omega 9 (27) (2024)
Ben K Ahiadu, Ami Grunbaum, Nicholas Rozza, Richard B Kremer, James F Rusling
Levels of Angiotensin and Kinin Metabolite Peptides Related to COVID-19 Severity. ACS pharmacology & translational science 7 (1) (2023)
Ben K Ahiadu, Ami Grunbaum, Nicholas Rozza, Richard B Kremer, James F Rusling
Levels of Angiotensin and Kinin Metabolite Peptides Related to COVID-19 Severity. ACS pharmacology & translational science 7 (1) (2023)
Marc-Antoine Lepage, Nicholas Rozza, Richard Kremer, Ami Grunbaum
Safety and effectiveness concerns of lopinavir/ritonavir in COVID-19 affected patients: a retrospective series. Clinical toxicology (Philadelphia, Pa.) 59 (7) (2021)